• US should prep for smallpox's return, experts say

    Smallpox, the only human disease to be fully eradicated, could reappear in the U.S. and across the globe, researchers said in a new report. 
  • Medtronic device recalled after Lifespan hospital reports infection cluster

    Providence-based Rhode Island Hospital saw an increase in external ventricular drain infections after switching to a Medtronic device that has since been recalled, the CDC said April 11.
  • 86% of post-surgery infections caused by preexisting skin bacteria: Study

    About 86% of infections following spine surgery could be linked to the patient's natural skin microbiome, a recent study from Seattle-based University of Washington School of Medicine found.
  • Health systems ease up on masking 

    Health systems are scaling back mask rules for staff, patients and visitors as respiratory virus season wanes.
  • Is CDC's C. diff framework effective? Jury is still out, study finds

    The CDC's framework to prevent healthcare-associated Clostridioides difficile infections may have potential benefits for hospitals, but further research is needed to fully understand its effectiveness, according to a study published March 27 in JAMA Network Open.
  • 2 steps 'get the drop' on surgical site infection: Study

    Physicians can reduce the risk of surgical site infections by using a nasal antiseptic before procedures, according to research published March 28 in the American Journal of Infection Control. 
  • CDC updates ventilation guidance for respiratory viruses

    The CDC acknowledged ventilation as a core strategy to prevent the spread of respiratory illnesses in a March 22 guidance update. 
  • COVID vaccines cut heart failure, clotting after infection: Study

    A recent study conducted by researchers in the U.K. found COVID-19 vaccines can reduce heart failure by up to 55% and blood clots by up to 78% after an infection.
  • Measles cases matches 2023 numbers: CDC

    Fifty-eight cases of measles have been reported in the first quarter of 2024, the same number of total cases in 2023, the CDC reported.
  • AI's potential for detecting HAIs in complex clinical scenarios

    AI tools might be able to diagnose healthcare-associated infections, but human oversight is vital to ensuring patient safety, according to a study published March 13 in the American Journal of Infection Control. 
  • MIS-C rates rose last fall

    Cases of multisystem inflammatory syndrome in children continue to be reported and saw a relative rise during fall 2023, the CDC reported.
  • EPA finalizes new sterilization standards

    The Environmental Protection Agency has issued a final rule that will reduce ethylene oxide emissions from commercial sterilization facilities.
  • CDC sends team to Chicago over measles outbreak

    The CDC has deployed a team to help address an ongoing measles outbreak that originated at a temporary migrant shelter in Chicago's Pilsen neighborhood, The Hill reported March 12.
  • Hospitals grapple with measles exposures

    An increase in measles activity this year is coinciding with a rise in potential exposures as infected individuals seek medical care at healthcare facilities across the nation.
  • Few hospitals screen for C. auris, survey finds

    In newly published findings from a survey of U.S. infectious disease physicians, only 37% said their facilities conduct screening for Candida auris, a fungus deemed an urgent public health threat due to its resistance to multiple antifungal treatments. 
  • New Jersey county reports suspected mumps outbreak

    The New Jersey Department of Health reported a cluster of suspected mumps in Hunterdon County.
  • 5 ways to optimize sepsis education: AMA

    The American Medical Association is underscoring the importance of robust sepsis training, particularly for new hires, as U.S. hospitals are increasingly under pressure to do more to reduce and prevent the 270,000 sepsis-induced deaths that occur annually.
  • Boston U accelerator funds vaccine for infant sepsis

    CARB-X, a Boston University-led nonprofit that funds projects that focus on antimicrobial stewardship, awarded $467,000 to GlyProVac to develop a maternal vaccine that could prevent sepsis in infants, according to a Feb. 29 news release.
  • C.diff guidelines revised for patients with recurrent infections

    A common practice for treating patients with gastrointestinal conditions has been revised by the American Gastroenterological Association, it announced Feb. 21.
  • Providence details improvements for prevention of sepsis in newborns

    Group B streptococcus is notorious for leading to sepsis in newborns. While there are guidelines for treating the condition, adhering to them is not always followed. 

Featured Whitepapers

Featured Webinars